Cardiovascular morbidity and mortality in patients with type 2 diabetes using novel antidiabetic medicines as add-on therapy: an observational real-world study

OBJECTIVE: To evaluate the effect of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA), compared with dipeptidyl peptidase-4 inhibitors (DPP-4i) as add-on therapy on cardiovascular (CV) morbidity and mortality in patients with type 2 diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Zerovnik, Spela, Kos, Mitja, Locatelli, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438902/
https://www.ncbi.nlm.nih.gov/pubmed/34518273
http://dx.doi.org/10.1136/bmjopen-2021-051549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438902/
https://www.ncbi.nlm.nih.gov/pubmed/34518273
http://dx.doi.org/10.1136/bmjopen-2021-051549

Ejemplares similares